Review article · 2024 · Open access

AI approaches for the discovery and validation of drug targets

Aaron Wenteler, Claudia Cabrera, Wei Wei, Victor Neduva, Michael R. Barnes

Cambridge Prisms Precision Medicine, 2, e7 · Published 24 May 2024 · DOI 10.1017/pcm.2024.4

Open PDFView at the publisherCite this paper

In brief

“AI approaches for the discovery and validation of drug targets” is a 2024 review article by Aaron Wenteler and 4 co-authors, published in Cambridge Prisms Precision Medicine. OpenAlex counts 53 citations as of 22 November 2026, which puts it in the top 6% of works published in 2024 by citations. It is open access under a CC BY licence: the full text is free to read at Cambridge Prisms Precision Medicine.

Citations
53
Most cited in
2026 (34)
Field-weighted impact
1.22
References
133
Authors
5

Abstract

Artificial intelligence (AI) holds immense promise for accelerating and improving all aspects of drug discovery, not least target discovery and validation. By integrating a diverse range of biological data modalities, AI enables the accurate prediction of drug target properties, ultimately illuminating biological mechanisms of disease and guiding drug discovery strategies. Despite the indisputable potential of AI in drug target discovery, there are many challenges and obstacles yet to be overcome, including dealing with data biases, model interpretability and generalisability, and the validation of predicted drug targets, to name a few. By exploring recent advancements in AI, this review showcases current applications of AI for drug target discovery and offers perspectives on the future of AI for the discovery and validation of drug targets, paving the way for the generation of novel and safer pharmaceuticals.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Wenteler, A., Cabrera, C., Wei, W., Neduva, V., & Barnes, M. R. (2024). AI approaches for the discovery and validation of drug targets. Cambridge Prisms Precision Medicine, 2, e7. https://doi.org/10.1017/pcm.2024.4

MLA 9

Wenteler, Aaron, et al. “AI approaches for the discovery and validation of drug targets.” Cambridge Prisms Precision Medicine, vol. 2, 2024, p. e7. https://doi.org/10.1017/pcm.2024.4.

Chicago

Wenteler, Aaron, Claudia Cabrera, Wei Wei, Victor Neduva, and Michael R. Barnes. 2024. “AI approaches for the discovery and validation of drug targets.” Cambridge Prisms Precision Medicine 2: e7. https://doi.org/10.1017/pcm.2024.4.

Harvard

Wenteler, A. et al. (2024) ‘AI approaches for the discovery and validation of drug targets’, Cambridge Prisms Precision Medicine, 2, p. e7. doi:10.1017/pcm.2024.4.

IEEE

A. Wenteler, C. Cabrera, W. Wei, V. Neduva, and M. R. Barnes, “AI approaches for the discovery and validation of drug targets,” Cambridge Prisms Precision Medicine, vol. 2, p. e7, 2024, doi: 10.1017/pcm.2024.4.

BibTeX

@article{wenteler2024approaches,
  title     = {{AI approaches for the discovery and validation of drug targets}},
  author    = {Wenteler, Aaron and Cabrera, Claudia and Wei, Wei and Neduva, Victor and Barnes, Michael R.},
  journal   = {Cambridge Prisms Precision Medicine},
  year      = {2024},
  volume    = {2},
  pages     = {e7},
  doi       = {10.1017/pcm.2024.4},
  url       = {https://doi.org/10.1017/pcm.2024.4}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202433
20251616
20263434

Its field-weighted citation impact is 1.22: it has been cited 1.22 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods

  • artificial intelligence
  • drug target identification
  • drug target validation
  • drug target prediction
  • data bias
  • model interpretability
  • generalizability
  • biological data integration

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Wenteler, A., Cabrera, C., Wei, W., Neduva, V., & Barnes, M. R. (2024). AI approaches for the discovery and validation of drug targets. Cambridge Prisms Precision Medicine, 2, e7. https://doi.org/10.1017/pcm.2024.4

How many times has this paper been cited?

53 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Cambridge Prisms Precision Medicine: sign in and open the PDF from this page.

Who wrote this paper?

Aaron Wenteler, Claudia Cabrera, Wei Wei, Victor Neduva, Michael R. Barnes.

What is the DOI of this paper?

10.1017/pcm.2024.4, permanently at https://doi.org/10.1017/pcm.2024.4. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.